Table 1 Minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of antimicrobial peptides against Acinetobacter baumannii 17,978, 19,606 and multiple drug-resistant (MDR) clinical strains.
Peptide | 17,978 | 19,606 | MDRAB clinical strains# | |||
|---|---|---|---|---|---|---|
MIC (μg/ml) | MBC (μg/ml) | MIC (μg/ml) | MBC (μg/ml) | MIC (μg/ml) | MBC (μg/ml) | |
A2 | 32 | 32 | 8 | 8 | 8–32 | 8–64 |
BMAP-27 | 16 | 16 | 8 | 8 | 4–16 | 8–32 |
CAME | 32 | 32 | 32 | 32 | 8–32 | 8–64 |
SMAP-29 | 8 | 8 | 8 | 8 | 4–32 | 4–64 |
H1a | 32 | 32 | 16 | 16 | 8–16 | 8–32 |
Latarcin 2a | 16 | 16 | 16 | 16 | 8–64 | 8–64 |
MaximinH2 | 64 | 128 | 32 | 32 | 16–128 | 16–128 |
NRC12 | 16 | 16 | 16 | 16 | 8–32 | 8–32 |
Pilosulin | 16 | 32 | 16 | 16 | 8–16 | 8–32 |
Pleurocidin | 16 | 16 | 16 | 16 | 8–32 | 8–32 |
Q6 | 16 | 16 | 16 | 16 | 8–16 | 8–32 |
TP4 | 16 | 16 | 16 | 16 | 8–32 | 8–32 |